Prophylactic and early outpatient treatment of COVID-19 in patients with kidney disease: considerations from the Immunonephrology Working Group of the European Renal Association (ERA-IWG).
腎臟疾病患者COVID-19的預防性和早期門診治療：來自歐洲腎臟協會（ERA-IWG）免疫腎病學工作組的考量。
Nephrol Dial Transplant 2023-08-02
Safety and efficacy of COVID-19 vaccines in patients on dialysis: a multicentre cohort study in Italy.
透析患者接受 COVID-19 疫苗的安全性和有效性：意大利多中心队列研究。
J Nephrol 2024-01-16
Safety and efficacy of pre-exposure prophylaxis with tixagevimab/cilgavimab (Evusheld) in patients with glomerular diseases who received rituximab.
接受利妥昔單抗治療的腎小球疾病患者使用提薪格呋單抗/西格格單抗（Evusheld）作為預防性暴露的安全性和有效性。
Clin Kidney J 2023-09-05
The impact of COVID-19 infection before the vaccination era on the hospitalized patients requiring hemodialysis: a single-center retrospective cohort.
COVID-19疫苗接種前感染對需要血液透析住院患者的影響：單中心回顧性研究。
Ren Fail 2023-09-24
Longitudinal SARS-CoV-2 neutralization of Omicron BA.1, BA.5 and BQ.1.1 after four vaccinations and the impact of breakthrough infections in haemodialysis patients.
血液透析患者接種四劑疫苗後對 Omicron BA.1、BA.5 及 BQ.1.1 的 SARS-CoV-2 中和效應的長期研究，以及突破性感染的影響。
Clin Kidney J 2023-12-05
Effectiveness of regdanvimab on mortality in COVID-19 infected patients on hemodialysis.
COVID-19感染患者在血液透析中使用regdanvimab對死亡率的有效性。
Kidney Res Clin Pract 2024-02-10
Safety and efficacy of tixagevimab/cilgavimab for pre-exposure prophylaxis in kidney transplant recipients: a multicenter retrospective cohort study.
腎移植接受者預防性暴露前治療 tixagevimab/cilgavimab 的安全性和有效性：多中心回顧性群體研究。
J Nephrol 2024-05-23